Pancreatic cancer, the uncontrollable cell growth in the pancrease, is one of the most lethal malignancies reported in the world.
Pancreatic cancer, the uncontrollable cell growth in the pancreas, is one
of the most lethal malignancies reported in the world. This is due to its late
diagnosis and limited response to treatment. The risk of the cancer is manifold
as there are no available prognosis methods to start treating pancreatic cancer
early, so that the patient’s life could be saved.
Hence, tractable methods to identify and interrogate the pathways that are
involved in the process of the creation of pancreatic tumor are urgently
needed. Scientists have newly developed organoid models, which are miniature
organs, grown in vitro, from normal and neoplastic murine and human pancreas
tissues in a new study addressing this issue. Pancreatic organoids have the
advantage of being generated from rejected tumors and biopsies, survive
cryo-preservation and exhibit ductal- and disease-stage-specific
characteristics.
The neoplastic organoids when orthotopically transplanted to the apt place, reiterate
the full spectrum of tumor development by forming early-grade neoplasms that
progress to locally invasive and metastatic carcinomas. The organoids are a
platform to probe genetic cooperation, due to their ability to be genetically
manipulated. A Comprehensive transcriptional and proteomic analysis of the
murine pancreatic organoids has revealed genes and pathways altered during the progression
of the cancer. It was found by the researchers that the confirmation of many of
these protein changes in human tissues demonstrates that organoids are a simplistic
model system to discover characteristics of the deadly pancreatic cancer malignancy.
Source-Medindia